Accolade, Inc. (ACCD) |
7.02 0 (0%) 04-08 16:00 |
Open: | 7.02 |
High: | 7.02 |
Low: | 7.02 |
Volume: | 4,543,947 |
Market Cap: | 576(M) |
PE Ratio: | -3.08 |
Exchange: | NASDAQ Global Select |
Industry: | Medical - Healthcare Information Services |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 8.21 |
Resistance 1: | 7.03 |
Pivot price: | 7.00 |
Support 1: | 6.98 |
Support 2: | 6.95 |
52w High: | 9.67 |
52w Low: | 3.08 |
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
EPS | -2.280 |
Book Value | 3.860 |
PEG Ratio | 0.00 |
Gross Profit | 2.623 |
Profit Margin (%) | -40.36 |
Operating Margin (%) | -22.71 |
Return on Assets (ttm) | -7.5 |
Return on Equity (ttm) | -48.2 |
Tue, 08 Apr 2025
Healthcare Giant Emerges: Transcarent-Accolade Merger Creates AI-Powered Platform Serving 20M Members - Stock Titan
Tue, 08 Apr 2025
Accolade Completes Merger, Plans Nasdaq Delisting - TipRanks
Tue, 08 Apr 2025
Accolade completes merger with Transcarent, shifts control - Investing.com
Sun, 06 Apr 2025
Accolade-Transcarent Merger: What It Means for Healthcare and Investors (ACCD All-Cash Acquisition) - tradingcalendar.com
Thu, 27 Mar 2025
Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewswire
Wed, 26 Mar 2025
Is Accolade Inc. (NASDAQ:ACCD) the Best Performing Stock So Far In 2025? - Yahoo Finance
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |